epidermal growth factor receptor inhibitorsEGFRIscancerSinoMedJoanna Briggs InstitutePubMedCNKIClinicalTrials.govWanfang DatabaseWHO International Clinical Trials Registry Platform+3 more
…he most common adverse effect in patients with cancer receiving epidermal growth factor receptor inhibitors (EGFRIs), which can impair quality of life and lead to treatmen…